Aspartate Aminotransferase/Alanine Aminotransferase Ratio: A Predictor of All-Cause Mortality Rate Among Japanese Community-Dwelling Individuals
- PMID: 38347978
- PMCID: PMC10859725
- DOI: 10.7759/cureus.52224
Aspartate Aminotransferase/Alanine Aminotransferase Ratio: A Predictor of All-Cause Mortality Rate Among Japanese Community-Dwelling Individuals
Abstract
Introduction An elevated ratio of aspartate aminotransferase (AST) to alanine aminotransferase (ALT) not only independently affects aging-related health but also plays a critical role in mortality. However, there is limited predictive data on all-cause mortality, particularly in the context of community-dwelling individuals in Japan. This study examined the association between the AST/ALT ratio and survival prognosis in a cohort study using two follow-up studies based on 19-year and 7-year intervals. Methods The study included 1,573 male (63 ± 14 years; range, 20-90 years) and 1,980 female participants (65 ± 12 years; range, 19-89 years). The participants were those involved in a Nomura cohort study conducted in 2002 (first cohort) and 2014 (second cohort) that continued to participate throughout the follow-up periods (follow-up rates were 90.3% and 97.4% for each cohort). A Cox proportional hazards model was adopted to calculate the multivariate-adjusted hazard ratios (HRs) of death from the baseline health check-up to the follow-up periods while controlling for potential confounding factors. Results The follow-up survey revealed that there were 473 male deaths (30.1% of total male participants) and 432 female deaths (21.8% of total female participants). The univariate Cox regression analysis showed that HRs for all-cause mortality were greater for participants in higher AST/ALT ratio quartiles (p < 0.001). The multivariate Cox regression analysis with adjusted variables showed a significant association between those in the fourth AST/ALT ratio quartile (HR: 1.83, 95% confidence interval, 1.46-2.29) and the risk of all-cause mortality. This association holds irrespective of gender, age, and elevated gamma-glutamyl transpeptidase, particularly in the case of participants with a body mass index < 25 kg/m2 without a history of cardiovascular disease or diabetes. Conclusions Our results reveal that an elevated AST/ALT ratio is an independent factor that can predict the risk of all-cause mortality among community-dwelling individuals.
Keywords: all-cause mortality; ast/alt ratio; biomarker; cohort study; community-dwelling individuals.
Copyright © 2024, Kawamoto et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Association between alanine aminotransferase and all-cause mortality rate: Findings from a study on Japanese community-dwelling individuals.J Clin Lab Anal. 2022 May;36(5):e24445. doi: 10.1002/jcla.24445. Epub 2022 Apr 18. J Clin Lab Anal. 2022. PMID: 35435277 Free PMC article.
-
Association of the Aspartate Aminotransferase to Alanine Aminotransferase Ratio with BNP Level and Cardiovascular Mortality in the General Population: The Yamagata Study 10-Year Follow-Up.Dis Markers. 2016;2016:4857917. doi: 10.1155/2016/4857917. Epub 2016 Oct 31. Dis Markers. 2016. PMID: 27872510 Free PMC article.
-
Loss of Life Expectancy by 10 Years or More From Elevated Aspartate Aminotransferase: Finding Aspartate Aminotransferase a Better Mortality Predictor for All-Cause and Liver-Related than Alanine Aminotransferase.Am J Gastroenterol. 2019 Sep;114(9):1478-1487. doi: 10.14309/ajg.0000000000000332. Am J Gastroenterol. 2019. PMID: 31425154
-
Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.Eur J Gastroenterol Hepatol. 2019 May;31(5):555-562. doi: 10.1097/MEG.0000000000001353. Eur J Gastroenterol Hepatol. 2019. PMID: 30614883
-
AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study.Lipids Health Dis. 2018 Dec 3;17(1):275. doi: 10.1186/s12944-018-0920-4. Lipids Health Dis. 2018. PMID: 30509277 Free PMC article. Review.
Cited by
-
Association between aspartate aminotransferase to alanine aminotransferase ratio and mortality in critically ill patients with end stage renal disease.Sci Rep. 2025 May 21;15(1):17714. doi: 10.1038/s41598-025-03027-2. Sci Rep. 2025. PMID: 40399564 Free PMC article.
References
-
- Lala V, Goyal A, Bansal P, Minter DA. StatPearls [Internet] Treasure Island (FL): StatPearls [Internet]; 2023. Liver Function Tests.
-
- Evaluation of abnormal liver-enzyme results in asymptomatic patients. Pratt DS, Kaplan MM. N Engl J Med. 2000;342:1266–1271. - PubMed
-
- An enzymic test for the diagnosis of viral hepatitis; the transaminase serum activities. De Ritis F, Coltorti M, Giusti G. Clin Chim Acta. 1957;2:70–74. - PubMed
-
- The ratio of aspartate aminotransferase to alanine aminotransferase (AST/ALT): the correlation of value with underlying severity of alcoholic liver disease. Gurung RB, Purbe B, Gyawali P, Risal P. Kathmandu Univ Med J (KUMJ) 2013;11:233–236. - PubMed
-
- The AST/ALT ratio as an indicator of cirrhosis in patients with PBC. Nyblom H, Björnsson E, Simrén M, Aldenborg F, Almer S, Olsson R. Liver Int. 2006;26:840–845. - PubMed
LinkOut - more resources
Full Text Sources